Suppr超能文献

重组白细胞介素-19 抑制实验性腹主动脉瘤的形成和进展。

Recombinant Interleukin-19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms.

机构信息

Divison of Vascular Surgery Department of Surgery Stanford University School of Medicine Stanford CA.

Division of Vascular Surgery Hamamatsu University School of Medicine Hamamatsu Shizuoka Japan.

出版信息

J Am Heart Assoc. 2021 Sep 7;10(17):e022207. doi: 10.1161/JAHA.121.022207. Epub 2021 Aug 28.

Abstract

Background Interleukin-19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin-19 expression in, and influences on, the formation and progression of experimental AAAs. Methods and Results Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10- to 12-week-old male mice via intra-aortic elastase infusion. Influence and potential mechanisms of interleukin-19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin-19 expression in both human and experimental AAAs. In mice, interleukin-19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth-muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin-19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin-19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin-19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C-C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine-expressing helper or cytotoxic T-cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin-19-treated mice. Interleukin-19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. Conclusions Based on human evidence and experimental modeling observations, interleukin-19 may influence the development and progression of AAAs.

摘要

背景

白细胞介素-19 是一种由免疫和非免疫细胞产生的免疫抑制细胞因子,但它在腹主动脉瘤(AAA)发病机制中的作用尚不清楚。本研究旨在探讨白细胞介素-19 在实验性 AAA 形成和进展中的表达及其影响。

方法和结果

从动脉瘤修复手术或移植供体中获得人类标本。通过主动脉内弹性蛋白酶输注在 10-12 周龄雄性小鼠中创建实验性 AAA。通过超声、组织病理学、流式细胞术和基因表达谱评估白细胞介素-19 治疗对 AAA 的影响和潜在机制。免疫组织化学显示人源和实验性 AAA 中白细胞介素-19 表达增强。在小鼠中,通过弹性蛋白酶输注在 AAA 形成前开始白细胞介素-19 治疗可抑制动脉瘤的形成和进展,减轻中膜弹性蛋白降解、平滑肌耗竭、白细胞浸润、新生血管形成以及基质金属蛋白酶 2 和 9 的表达。在 AAA 形成后开始白细胞介素-19 治疗可限制进一步的动脉瘤变性。在额外的实验中,白细胞介素-19 治疗抑制了腹腔内巯基醋酸注射后的小鼠巨噬细胞募集。在体外经典或替代激活的巨噬细胞中,白细胞介素-19 下调了诱导型一氧化氮合酶、趋化因子 C-C 基元配体 2 和基质金属蛋白酶 2 和 9 的 mRNA 表达,但对动脉瘤主动脉或白细胞介素-19 治疗小鼠脾脏中的辅助或细胞毒性 T 细胞分化或调节性 T 细胞的细胞因子表达没有明显影响。白细胞介素-19 还抑制了高脂血症小鼠中血管紧张素 II 输注引起的 AAA。

结论

基于人类证据和实验模型观察,白细胞介素-19 可能影响 AAA 的发生和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1c7/8649236/47c9e5051b3a/JAH3-10-e022207-g004.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验